Form 8-K - Current report:
SEC Accession No. 0000950170-25-091613
Filing Date
2025-06-30
Accepted
2025-06-30 16:26:17
Documents
11
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20250630.htm   iXBRL 8-K 50336
2 EX-99.1 crnx-ex99_1.htm EX-99.1 72956
  Complete submission text file 0000950170-25-091613.txt   236611

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20250630.xsd EX-101.SCH 23893
13 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250630_htm.xml XML 4534
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 251092412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)